Tonix Pharmaceuticals Holding (TNXP) Shares Outstanding (2014 - 2026)

Tonix Pharmaceuticals Holding has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $16.8 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 122.52% year-over-year to $16.8 million in Q2 2026; TTM through Jun 2026 was $16.8 million, a 122.52% increase from a year earlier, with the FY2025 full-year figure at $8.5 million, up 1055.9% from the prior year.
• Shares Outstanding (Entity) was $16.8 million for Q2 2026 at Tonix Pharmaceuticals Holding, up from $14.2 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $16.8 million in Q2 2026, with the low at $870.0 in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $3.6 million, with a median of $31945.0 recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) sank 94.0% in 2022, then soared 29752.93% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $1787.0 in 2022, then soared by 197.99% to $5325.0 in 2023, then jumped by 13727.96% to $736339.0 in 2024, then soared by 1055.9% to $8.5 million in 2025, then jumped by 97.29% to $16.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $16.8 million (Q2 2026), $14.2 million (Q1 2026), and $8.5 million (Q4 2025), per Business Quant data.